Literature DB >> 16042571

The role of the Wnt signalling pathway in colorectal tumorigenesis.

J Behrens1.   

Abstract

Colorectal cancer (CRC) is the second largest cause of cancer-related deaths in Western countries. CRC arises from the colorectal epithelium as a result of the accumulation of genetic alterations in defined oncogenes and tumour suppressor genes. Mutations in the tumour suppressor APC (adenomatous polyposis coli) genes occur early in the development of CRC and lead to the stabilization of the Wnt pathway component beta-catenin and to the constitutive activation of Wnt signalling. Stabilizing mutations of beta-catenin can also lead to its accumulation, qualifying beta-catenin as a proto-oncogene. Here I will summarize the biochemical interactions occurring in Wnt signalling and describe how alterations in Wnt pathway components lead to CRC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042571     DOI: 10.1042/BST0330672

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  54 in total

Review 1.  DNA Methylation Dynamics During Differentiation, Proliferation, and Tumorigenesis in the Intestinal Tract.

Authors:  Can-Ze Huang; Tao Yu; Qi-Kui Chen
Journal:  Stem Cells Dev       Date:  2015-10-20       Impact factor: 3.272

Review 2.  Role of beta-catenin in the adult liver.

Authors:  Frank J Gonzalez
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

3.  Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cells.

Authors:  T-H Hsu; S-Y Jiang; W-L Chang; W-L Chan; R L Eckert; T M Scharadin; T-C Chang
Journal:  Cell Death Differ       Date:  2014-11-07       Impact factor: 15.828

4.  Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Authors:  Yutaka Suehiro; Chi Wai Wong; Lucian R Chirieac; Yutaka Kondo; Lanlan Shen; C Renee Webb; Yee Wai Chan; Annie S Y Chan; Tsun Leung Chan; Tsung-Teh Wu; Asif Rashid; Yuichiro Hamanaka; Yuji Hinoda; Rhonda L Shannon; Xuemei Wang; Jeffrey Morris; Jean-Pierre J Issa; Siu Tsan Yuen; Suet Yi Leung; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

5.  Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study.

Authors:  Albert A Baskar; Savarimuthu Ignacimuthu; Gabriel M Paulraj; Khalid S Al Numair
Journal:  BMC Complement Altern Med       Date:  2010-06-04       Impact factor: 3.659

6.  Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling.

Authors:  Young-Ok Son; Lei Wang; Pratheeshkumar Poyil; Amit Budhraja; J Andrew Hitron; Zhuo Zhang; Jeong-Chae Lee; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-03       Impact factor: 4.219

7.  Reactive oxygen species mediate Cr(VI)-induced carcinogenesis through PI3K/AKT-dependent activation of GSK-3β/β-catenin signaling.

Authors:  Young-Ok Son; Poyil Pratheeshkumar; Lei Wang; Xin Wang; Jia Fan; Dong-Hern Kim; Ju-Yeon Lee; Zhuo Zhang; Jeong-Chae Lee; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219

8.  Expression and localization of axin 2 in colorectal carcinoma and its clinical implication.

Authors:  Ute Schaal; Sandra Grenz; Susanne Merkel; Tilman T Rau; Michel V Hadjihannas; Elisabeth Kremmer; Priya Chudasama; Roland S Croner; Jürgen Behrens; Michael Stürzl; Elisabeth Naschberger
Journal:  Int J Colorectal Dis       Date:  2013-05-24       Impact factor: 2.571

9.  DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development.

Authors:  Yukun Zhang; Qian Li; Hong Chen
Journal:  Carcinogenesis       Date:  2013-04-18       Impact factor: 4.944

10.  TCF/beta-catenin plays an important role in HCCR-1 oncogene expression.

Authors:  Goang-Won Cho; Mi-Hwa Kim; Seung Hyun Kim; Seon-Ah Ha; Hyun Kee Kim; Sanghee Kim; Jin W Kim
Journal:  BMC Mol Biol       Date:  2009-05-12       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.